HOME > BUSINESS
BUSINESS
- Avigan-Administered French Ebola Patient Recovers
October 7, 2014
- AnGes MG Commences Patient Registration in US for Collategene PIII Study
October 7, 2014
- Januvia Remains No. 1, Trazenta Climbs to No. 2 in GP Market in Anterio’s “Mind Share” Ranking for August
October 6, 2014
- JCR Pharmaceuticals Hopes to Make Japan’s First Cell Product into New Profit Pillar
October 6, 2014
- Takeda Directors Face 3-Month Pay Cut over CASE-J Issue
October 6, 2014
- Daiichi Sankyo Opens Representative Office in Vietnam
October 6, 2014
- Takeda to Invest in Alfresa Corporation’s Vaccine-Related Subsidiary
October 6, 2014
- Eisai Launches Halaven in Australia
October 3, 2014
- Santen Completes Transfer of Ophthalmology Assets from Merck
October 3, 2014
- Jim Murphy, GM of Alcon US Vision Care, Leads Alcon Japan as New President
October 3, 2014
- MTPC Charges Ahead with Research Lab Overhaul to Buttress Drug Discovery
October 2, 2014
- Daiichi Sankyo Seeks Tuberculosis Indication for Cravit, AGs
October 2, 2014
- MTPC Paid 19.8 Billion Yen to Physicians, Medical Institutions in FY2013
October 2, 2014
- Novartis Pharma Notifies PMDA of Additional 1,299 Unreported Serious ADRs
October 2, 2014
- AZ Starts J-DISCOVER Observational Study of Type 2 Diabetes Management
October 2, 2014
- Sumitomo Dainippon Obtains Patent License from Dnavec for Production of Clinical iPS Cells
October 2, 2014
- Kissei to Spice Up Current Portfolio in Next 3 Years, Launch New Drugs Later
October 1, 2014
- Takeda, MacroGenics Sign Second Agreement to Develop Autoimmune Disease Treatments
October 1, 2014
- Sumitomo Dainippon’s FY2013 Payments to Healthcare Professionals at 13.1 Billion Yen
October 1, 2014
- Kyowa Kirin, Pfizer to Collaborate on Cancer Immunotherapy
October 1, 2014
ページ
As CEO of Morunda, I had the privilege of interviewing Bill Schuster, Country Manager of Viatris in South Korea. Our conversation delved into the multifaceted nature of leadership in the healthcare industry, exploring challenges, successes, and the power of authenticity.A…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…